MEDIGENE AG NPV revenue breakdown overview

MEDIGENE AG NPV revenue for the last year amounted to 6.00 M EUR, the most of which — 6.03 M EUR — came from its highest performing source at the moment, Immunotherapies, the year earlier bringing 31.25 M EUR. The greatest contribution to the revenue figure was made by Germany — last year it brought MEDIGENE AG NPV 6.03 M EUR, and the year before that — 25.11 M EUR.